Dose-Escalation Study of Azacitidine Followed By High-Dose Cytarabine (HiDAC) and Mitoxantrone (Mito) for Remission Induction in High-Risk Acute Myeloid Leukemia (AML)

被引：2

作者：

Karimi, Yasmin H. ^{[1
]}

Jain, Nitin ^{[2
]}

Green, Margaret ^{[1
]}

Godley, Lucy A. ^{[1
]}

Weiner, Howie Lawrence ^{[1
]}

Malnassy, Gregory ^{[1
]}

Fulton, Noreen ^{[1
]}

Artz, Andrew ^{[1
]}

Liu, Hongtao ^{[1
]}

Thirman, Michael J. ^{[1
]}

Daunov, Michael ^{[1
]}

Larson, Richard A. ^{[1
]}

Stock, Wendy ^{[1
]}

Odenike, Olatoyosi ^{[1
]}

机构：

[1] Univ Chicago, Med Ctr, Chicago, IL 60637 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

10.1182/blood.V126.23.118.118

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[41] Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy
Kam, Grace
Yiu, Richard
Loh, Yvonne
Ang, Ai Leen
Yueh, Ling Ling
Goh, Yeow Tee
Wong, Gee Chuan
SUPPORTIVE CARE IN CANCER, 2015, 23 (03) : 643 - 649
[42] Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia—a phase 3 study
Jan Braess
Susanne Amler
Karl-Anton Kreuzer
Karsten Spiekermann
Hans Walter Lindemann
Eva Lengfelder
Ullrich Graeven
Peter Staib
Wolf-Dieter Ludwig
Harald Biersack
Yon-Dschun Ko
Michael J. Uppenkamp
Maike De Wit
Stefan Korsten
Rudolf Peceny
Tobias Gaska
Xaver Schiel
Dirk M. Behringer
Michael G. Kiehl
Bettina Zinngrebe
Gerald Meckenstock
Eva Roemer
Dirk Medgenberg
Ernst Spaeth-Schwalbe
Gero Massenkeil
Heidrun Hindahl
Rainer Schwerdtfeger
Guido Trenn
Cristina Sauerland
Raphael Koch
Martin Lablans
Andreas Faldum
Dennis Görlich
Stefan K. Bohlander
Stephanie Schneider
Annika Dufour
Christian Buske
Michael Fiegl
Marion Subklewe
Birgit Braess
Michael Unterhalt
Anja Baumgartner
Bernhard Wörmann
Dietrich Beelen
Wolfgang Hiddemann
Leukemia, 2018, 32 : 2558 - 2571
[43] Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy
Grace Kam
Richard Yiu
Yvonne Loh
Ai Leen Ang
Ling Ling Yueh
Yeow Tee Goh
Gee Chuan Wong
Supportive Care in Cancer, 2015, 23 : 643 - 649
[44] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN ADULT ACUTE MYELOID-LEUKEMIA
MARCUS, RE
CATOVSKY, D
GOLDMAN, JM
GALTON, DAG
NEWLAND, AC
SLOCOMBE, G
HEGDE, U
LANCET, 1985, 1 (8442): : 1384 - 1384
[45] Double induction strategy for acute myeloid leukemia:: The effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine:: A randomized trial by the German AML Cooperative Group
Büchner, T
Wörmann, B
Löffler, H
Gassmann, W
Haferlach, T
Fonatsch, C
Haase, D
Schoch, C
Hossfeld, D
Lengfelder, E
Aul, C
Heyll, A
Maschmeyer, G
Ludwig, WD
Sauerland, MC
Heinecke, A
BLOOD, 1999, 93 (12) : 4116 - 4124
[46] INDUCTION THERAPY WITH HIGH-DOSE CYTARABINE AND ANTHRACYCLINES IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
Gil, Perez Angela
Vazquez, Ramo Alejandro
De Rojas, de Pablo Teresa
Torralba, Gomez de Suso Miguel
Nuevo, Lopez Irene
Subira, Perez Dolores
Merchan, Munoz Beatriz
Perez, Ortega Alba
De Miguel, Llorente Dunia
HAEMATOLOGICA, 2020, 105 : 384 - 385
[47] Results of high-dose cytarabine consolidation and interferon alpha maintenance therapy in acute myeloid leukemia (AML)
Saikia, TK
Advani, SH
Gopal, R
Nair, CN
Sawant, VS
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 226 - 226
[48] Importance of albumin level on outcomes of high-dose cytarabine and mitoxantrone induction therapy for AML.
Burhani, Mansoor
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[49] High dose idarubicin (HIda) with high dose cytarabine (HiDac) as induction therapy for newly diagnosed patients with AML.
Maslak, P
Weiss, M
Jurcic, J
Jimenez, J
Berman, E
Golde, D
Scheinberg, D
BLOOD, 1998, 92 (10) : 231A - 231A
[50] Pixy-321 in combination with high dose cytarabine end mitoxantrone in poor prognosis acute myeloid leukemia (AML).
Feldman, E
Geller, RB
Seiter, K
Heffner, L
Stuart, R
Bhalla, K
BLOOD, 1995, 86 (10) : 2068 - 2068

← 1 2 3 4 5 →